(Q36576954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Drug insight: Recent advances in male hormonal contraception (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Stephanie T Page

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

William J Bremner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Endocrinology and Metabolism

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

32-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

Unintended pregnancy among the urban poor

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

Unintended Pregnancy in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Trends in contraceptive use in the United States: 1982-1995

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Attitudes toward male fertility control: results of a multinational survey on four continents

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Would women trust their partners to use a male pill?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Contraceptive efficacy of testosterone-induced azoospermia in normal men

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Contraceptive efficacy of a depot progestin and androgen combination in men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Testosterone for male contraception during one year: attitudes, well-being and quality of sex life

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Evidence for the acceptability of an injectable hormonal method for men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Norethisterone enanthate has neither a direct effect on the testis nor on the epididymis: a study in adult male cynomolgus monkeys (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Pharmacology of antiandrogens

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Low dose of cyproterone acetate and testosterone enanthate for contraception in men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in chinese men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

A single dose of the potent gonadotropin-releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

A selective androgen receptor modulator for hormonal male contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Oral testosterone in oil plus dutasteride in men: a pharmacokinetic study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0069

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932251%20AND%20SRC:MED&resulttype=core&format=json

release_w3zwgnaft5hrlb36ngnnthtndq

29 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w3zwgnaft5hrlb36ngnnthtndq

24 November 2022

mapped directly with Wikidata item

1 reference